Vir Biotechnology, Inc.
US ˙ NasdaqGS ˙ US92764N1028

SecurityVIR / Vir Biotechnology, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership2,854,205 shares
Latest Disclosed Value $ 25,573,682
Morgan Stanley reports 6.53% increase in ownership of VIR / Vir Biotechnology, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 2,854,205 shares of Vir Biotechnology, Inc. (US:VIR) valued at $25,573,677 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 2,679,145 shares of Vir Biotechnology, Inc.. This represents a change in shares of 6.53% during the quarter. The current value of the position is $26,115,976 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F VIR BIOTECHNOLOGY COM 92764N102 2,854,205 175,060 6.53 25,574 58.30 0.0015
2026-05-27 2025-12-31 13F/A-1 VIR BIOTECHNOLOGY COM 92764N102 2,679,145 -9,973 -0.37 16,155 5.22 0.0010
2026-02-13 2025-12-31 13F VIR BIOTECHNOLOGY COM 92764N102 2,679,145 -9,973 16,155 0.0010
2026-05-27 2025-09-30 13F/A-1 VIR BIOTECHNOLOGY COM 92764N102 2,689,118 1,055,428 64.60 15,355 86.49 0.0009
2025-11-14 2025-09-30 13F VIR BIOTECHNOLOGY COM 92764N102 2,689,118 1,055,428 15,355 0.0009
2025-08-15 2025-06-30 13F VIR BIOTECHNOLOGY COM 92764N102 1,633,690 209,345 14.70 8,234 -10.79 0.0005
2025-05-15 2025-03-31 13F VIR BIOTECHNOLOGY COM 92764N102 1,424,345 300,539 26.74 9,230 11.89 0.0007
2025-05-15 2024-12-31 13F/A-1 VIR BIOTECHNOLOGY COM 92764N102 1,123,806 -113,113 -9.14 8,249 -10.97 0.0006
2025-02-14 2024-12-31 13F VIR BIOTECHNOLOGY COM 92764N102 1,123,806 -113,113 8,249 0.0006
2025-05-14 2024-09-30 13F/A-2 VIR BIOTECHNOLOGY COM 92764N102 1,236,919 -886,293 -41.74 9,265 -50.97 0.0007
2025-02-14 2024-09-30 13F/A-1 VIR BIOTECHNOLOGY COM 92764N102 1,236,919 -886,293 9,265 0.0007
2024-11-14 2024-09-30 13F VIR BIOTECHNOLOGY COM 92764N102 1,236,919 -886,293 9,265 0.0007
2025-05-14 2024-06-30 13F/A-2 VIR BIOTECHNOLOGY COM 92764N102 2,123,212 -216,048 -9.24 18,897 -20.26 0.0015
2024-10-17 2024-06-30 13F/A-1 VIR BIOTECHNOLOGY COM 92764N102 2,123,212 -216,048 18,897 0.0015
2024-08-14 2024-06-30 13F VIR BIOTECHNOLOGY COM 92764N102 2,123,212 -216,048 18,897 0.0015
2024-10-17 2024-03-31 13F/A-2 VIR BIOTECHNOLOGY COM 92764N102 2,339,260 212,981 10.02 23,697 10.78 0.0019
2024-08-16 2024-03-31 13F/A-1 VIR BIOTECHNOLOGY COM 92764N102 2,339,260 212,981 23,697 0.0002
2024-05-15 2024-03-31 13F VIR BIOTECHNOLOGY COM 92764N102 2,339,260 212,981 23,697 0.0019
2024-08-16 2023-12-31 13F/A-1 VIR BIOTECHNOLOGY COM 92764N102 2,126,279 738,863 53.25 21,390 64.54 0.0019
2024-02-13 2023-12-31 13F VIR BIOTECHNOLOGY COM 92764N102 2,126,279 738,863 21,390 0.0019
2023-11-15 2023-09-30 13F VIR BIOTECHNOLOGY COM 92764N102 1,387,416 697,690 101.15 13,000 -23.16 0.0013
2023-08-14 2023-06-30 13F VIR BIOTECHNOLOGY COM 92764N102 689,726 90,868 15.17 16,919 21.41 0.0017
2023-05-15 2023-03-31 13F VIR BIOTECHNOLOGY COM 92764N102 598,858 -578,970 -49.16 13,935 -53.25 0.0015
2023-02-14 2022-12-31 13F VIR BIOTECHNOLOGY COM 92764N102 1,177,828 32,170 2.81 29,811 34.96 0.0034
2022-11-14 2022-09-30 13F VIR BIOTECHNOLOGY COM 92764N102 1,145,658 64,284 5.94 22,088 -19.81 0.0030
2022-10-27 2022-06-30 13F/A-1 VIR BIOTECHNOLOGY COM 92764N102 1,081,374 489,696 82.76 27,544 81.00 0.0036
2022-08-15 2022-06-30 13F VIR BIOTECHNOLOGY COM 92764N102 1,081,374 489,696 27,544 0.0007
2022-10-27 2022-03-31 13F/A-1 VIR BIOTECHNOLOGY COM 92764N102 591,678 -639,416 -51.94 15,218 -70.48 0.0021
2022-05-13 2022-03-31 13F VIR BIOTECHNOLOGY COM 92764N102 591,678 -639,416 15,218 0.0021
2022-02-14 2021-12-31 13F VIR BIOTECHNOLOGY COM 92764N102 1,231,094 1,086,524 751.56 51,546 719.36 0.0064
2021-11-15 2021-09-30 13F VIR BIOTECHNOLOGY COM 92764N102 144,570 -194,647 -57.38 6,291 -60.77 0.0008
2021-08-23 2021-06-30 13F/A-1 VIR BIOTECHNOLOGY COM 92764N102 339,217 -63,424 -15.75 16,038 -22.31 0.0021
2021-08-16 2021-06-30 13F VIR BIOTECHNOLOGY COM 92764N102 339,217 -63,424 16,038 0.0004
2021-05-17 2021-03-31 13F VIR BIOTECHNOLOGY COM 92764N102 402,641 308,307 326.82 20,643 717.22 0.0030
2021-02-16 2020-12-31 13F VIR BIOTECHNOLOGY COM 92764N102 94,334 53,525 131.16 2,526 80.30 0.0004
2020-11-13 2020-09-30 13F VIR BIOTECHNOLOGY COM 92764N102 40,809 12,350 43.40 1,401 20.15 0.0003
2020-08-14 2020-06-30 13F VIR BIOTECHNOLOGY COM 92764N102 28,459 10,073 54.79 1,166 85.08 0.0003
2020-05-26 2020-03-31 13F/A-1 VIR BIOTECHNOLOGY COM 92764N102 18,386 2,934 18.99 630 223.08 0.0002
2020-05-15 2020-03-31 13F VIR BIOTECHNOLOGY COM 92764N102 18,386 2,934 630 170.8947
2020-02-14 2019-12-31 13F VIR BIOTECHNOLOGY COM 92764N102 15,452 15,452 195 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.